Rennova Health Signs Agreement with Academy Medical to Provide Laboratory Services to U.S. Federal Government Customers
11 Agosto 2016 - 7:30AM
Business Wire
Includes All Federal Government Facilities
Including VA Hospitals
Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a
vertically integrated provider of industry-leading diagnostics and
supportive software solutions to healthcare providers, announces
the signing of a contract with Academy Medical, LLC, a
Service-Disabled Veteran-Owned Small Business, to promote the sale
of services to the United States federal government. Academy has
substantial experience in establishing, operating and maintaining
effective sales channels, contract vehicles and business protocols,
with a principal focus on federal government customers of medical
services and supplies.
This agreement confirms Rennova’s Riviera Beach Laboratory’s
appointment as its exclusive federal government business channel
partner to provide for the sale of the services to federal
government customers, including U.S. Department of Veterans
Affairs, U.S. Department of Defense and U.S. Health and Human
Services facilities, among others, as well as non-government and
commercial institutional customers.
“The signing of this contract with Academy Medical is an
excellent step forward for Rennova Health, as it opens up an
important, very large market for our testing services,” said Seamus
Lagan, chief executive officer of Rennova Health. “In particular,
we look forward to providing not only a broad panel of traditional
tests, but also key pharmacogenomics tests. A growing number of
pharmaceutical products contain guidance for pharmacogenetics
biomarker testing in their labels, and the Department of Veterans
Affairs in particular has shown an increased awareness of the
utility of this type of testing. Importantly, this agreement with
Academy Medical, while providing for a substantial broadening of
the market for our laboratory tests, also provides for a reliable
payment mechanism,” added Mr. Lagan.
“We are excited to partner with Rennova Health for laboratory
tests within U.S. federal government facilities,” said Edward
Desser, Chief Executive Officer of Academy Medical. “In addition to
Rennova being able to provide a full complement of diagnostics, we
were impressed by the company’s strict compliance procedures. We
look forward to a mutually productive relationship.”
About Academy Medical, LLC
Academy Medical is a certified Service-Disabled Veteran-Owned
Small Business specializing in providing innovative orthopedic
implants, allograft tissue, wound care products and other medical
devices. As healthcare needs change, Academy Medical prides itself
on being a leading edge provider with its ability to adapt and
engage with both healthcare professionals and facilities to provide
solutions to the many challenges the healthcare sector faces.
Academy Medical is a nationwide supplier to Department of Veteran
Affairs and Department of Defense hospitals, Indian Health Service
clinics and other governmental health facilities. Academy Medical,
based in West Palm Beach, Fla., also serves civilian hospitals
throughout Florida, and in select markets nationwide. For more
information about Academy Medical, LLC. please visit
www.academymedical.net
About Rennova Health, Inc.
Rennova Health, Inc. (NASDAQ: RNVA) provides industry-leading
diagnostics and supportive software solutions to healthcare
providers, delivering an efficient, effective patient experience
and superior clinical outcome. Through an ever-expanding group of
strategic brands that work in unison to empower customers, we are
creating the next generation of healthcare. For more information
about Rennova Health, Inc., visit www.rennovahealth.com.
Rennova Health Safe Harbor Statement
This press release includes forward-looking statements about
Rennova Health’s anticipated results that involve risks and
uncertainties, including statements regarding our expectations with
respect to the completion of our proposed public offering and the
gross proceeds from the offering. These statements are subject to
significant risks and uncertainties, actual results could differ
materially from those projected and Rennova Health cautions
investors not to place undue reliance on the forward-looking
statements contained in this release. There can be no assurance
that Rennova Health will be able to complete the offering on the
anticipated terms, or at all. Risks and uncertainties relating to
Rennova Health and this offering can be found in the “Risk Factors”
section of the preliminary prospectus and final prospectus related
to such proposed offering to be filed with the SEC. Rennova Health
undertakes no obligation to update or revise any such
forward-looking statements to reflect subsequent events or
circumstances, except as may be required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160811005090/en/
Rennova HealthSebastien Sainsbury,
561-666-9818ssainsbury@rennovahealth.comorInvestorsLHAKim Golodetz,
212-838-3777Kgolodetz@lhai.comorBruce Voss,
310-691-7100Bvoss@lhai.com
Rennova Health - Warrant (NASDAQ:RNVAZ)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Rennova Health - Warrant (NASDAQ:RNVAZ)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024